Related Experiment Video
Updated: Jul 3, 2026

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection
Damon P Eisen1, Melinda M Dean, Marja A Boermeester
1Centre for Clinical Research Excellence in Infectious Diseases, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia. damon.eisen@mh.org.au
Background:
Previous studies have shown associations between low mannose-binding lectin (MBL) level or variant MBL2 genotype and sepsis susceptibility. However, MBL deficiency has not been rigorously defined, and associations with sepsis outcomes have not been subjected to multivariable analysis.
Methods:
We reanalyzed MBL results in a large cohort with use of individual data from 4 studies involving a total of 1642 healthy control subjects and systematically defined a reliable deficiency cutoff. Subsequently, data were reassessed to extend previous MBL and sepsis associations, with adjustment for known outcome predictors. We reanalyzed individual data from 675 patients from 5 adult studies and 1 pediatric study of MBL and severe bacterial infection.
Results:
XA/O and O/O MBL2 genotypes had the lowest median MBL concentrations. Receiver operating characteristic analysis revealed that an MBL cutoff value of 0.5 microg/mL was a reliable predictor of low-producing MBL2 genotypes (sensitivity, 82%; specificity, 82%; negative predictive value, 98%). MBL deficiency was associated with increased likelihood of death among patients with severe bacterial infection (odds ratio, 2.11; 95% confidence interval, 1.30-3.43). In intensive care unit-based studies, there was a trend toward increased risk of death among MBL-deficient patients (odds ratio, 1.58; 95% confidence interval, 0.90-2.77) after adjustment for Acute Physiology and Chronic Health Enquiry II score. The risk of death was increased among MBL-deficient patients with Streptococcus pneumoniae infection (odds ratio, 5.62; 95% confidence interval, 1.27-24.92) after adjustment for bacteremia, comorbidities, and age.
Conclusions:
We defined a serum level for MBL deficiency that can be used with confidence in future studies of MBL disease associations. The risk of death was increased among MBL-deficient patients with severe pneumococcal infection, highlighting the pathogenic significance of this innate immune defence protein.
Insights
Low mannose-binding lectin (MBL) levels are linked to increased sepsis mortality, especially in severe pneumococcal infections. A defined MBL deficiency cutoff of 0.5 microg/mL aids future research into this innate immune protein.
Area of Science:
- Immunology
- Infectious Diseases
- Genetics
Background:
- Previous studies suggest a link between low mannose-binding lectin (MBL) levels or MBL2 genotypes and sepsis susceptibility.
- However, MBL deficiency lacks a rigorous definition, and its impact on sepsis outcomes requires further investigation through multivariable analysis.
Purpose of the Study:
- To rigorously define MBL deficiency using a reliable cutoff value.
- To investigate the association between MBL deficiency and sepsis outcomes, including mortality, using multivariable analysis.
Main Methods:
- Reanalyzed MBL data from 1642 healthy controls across 4 studies to establish a deficiency cutoff.
- Utilized receiver operating characteristic analysis to determine a reliable MBL cutoff value.
- Reassessed individual data from 675 patients across 6 studies (adult and pediatric) of MBL and severe bacterial infection, adjusting for known outcome predictors.
Main Results:
- XA/O and O/O MBL2 genotypes exhibited the lowest MBL concentrations.
- An MBL cutoff of 0.5 microg/mL reliably identified low-producing MBL2 genotypes (82% sensitivity, 82% specificity).
- MBL deficiency was associated with increased mortality in severe bacterial infections (OR, 2.11) and significantly in Streptococcus pneumoniae infections (OR, 5.62) after adjustments.
Conclusions:
- A serum MBL level of 0.5 microg/mL is defined as a reliable indicator of MBL deficiency for future studies.
- MBL deficiency increases mortality risk in severe pneumococcal infections, underscoring the role of MBL in innate immunity.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis
Pneumonia I: Introduction
Cryptococcal Meningitis
Pneumonia III: Complications and Assessment